Autoimmune Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
32
NCT07059312
A Phase 1 Study of JADE101 in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 17, 2025
Completion: Oct 31, 2026
Loading map...